Anda di halaman 1dari 4

4th Annual

Pharmaceutical PLM
Maximising return on investment through product life cycle management

14th - 15th September 2010, BSG Conference Centre, London, UK BOOK NOW!

Key Speakers
Jonathan Deutsch, Director Pharma Development Safety, Licensing and Early Development, Hoffmann-La Roche

Marc Sluijs, EMEA Business Development Director Life Sciences, Oracle

Ralph C. Schimmer, Global Head Drug Safety Sciences - Metabolism and Cardiovascular, Hoffmann-La Roche

Vishal K. Gupta, Director Pharmaceutical R&D, Covidien

Alok Aggarwal, Co-Founder and Chairman, Evalueserve

Alexandra C. Gruber, Director Business Development & Marketing, BIOCRATES Life Sciences

Mike Rea, Chief Executive Officer, IdeaPharma

Peter G Nielsen, Executive Vice President of Pharmaceutical Development and Chemistry Manufacturing &
Control, Lifecycle Pharma

Nigel Stoate, Partner, Taylor Wessing

Paul FitzGerald, Owner, Syntropy Medica

Martin Hawkins, Executive Director, Sun Brand Technologies


Driving the Industry Forward |

Media Partners

To Book Call: +91 022 27578668 |

Conference Introduction
4th Annual Pharmaceutical PLM
14th - 15th September 2010, London, UK

Associate Sponsors:
Dear Colleague, Sun Brand Technologies (SBT) is the market leading specialist in Brand
Lifecycle Management (BLM) and Product Lifecycle Management
harmaceutical and biopharmaceutical companies are under severe (PLM) solutions that optimise speed of product to market and deliver
pressure to improve product pipelines, accelerate time to market, real business savings. Our sophisticated ODIN solution is a platform for recording all New
Product Development activities within a business, complimented by an end user interface
and improve margins on existing products, while maintaining strict encompassing intuitive Project Management and Artwork Approval tools. The ODIN
adherence to quality principles and regulatory requirements. It is application runs via a web browser making it easily accessible from anywhere in the world.
imperative that pharmaceutical and biotech companies address The product has been developed and managed by industry experts, highly skilled system
architects and experienced developers, but above all was built by end users for end users.
these business challenges to stay competitive, increase revenue, For further information please email:
enhance profi t, and reduce the risk of noncompliance. Infosys (NASDAQ: INFY) defi nes, designs and delivers IT-enabled business
solutions that help Global 2000 companies win in a Flat World. These
4th Annual Pharmaceutical PLM Conference will feature solutions focus on providing strategic differentiation and operational
keynote addresses, presentations, case studies and interactive superiority to clients. With Infosys, clients are assured of a transparent business partner, world-
discussions from development to commercialisation, quality control, class processes, speed of execution and the power to stretch their IT budget by leveraging the
Global Delivery Model that Infosys pioneered. Infosys has over 105,000 employees in over 50
supplier issues, regulation and inspection. Please be sure to register offi ces worldwide. Infosys is part of the NASDAQ-100 Index and The Global Dow. PLM, a part of
your participation amongst the industry’s elite for this intensive two- Global Engineering has been a major focus for Infosys, in which it partnered with many leading
day of learning, networking and exploiting business opportunities. pharmaceutical majors in realizing full potential of their PLM initiatives.
For further information please visit
I look forward to seeing you all in London. Media Partners: is the leading industry-sponsored portal for
Best regards the pharmaceutical sector. Supported by most of the leading
pharmaceutical corporations, provides dynamic real-time news, features,
events listings and international jobs to industry professionals across Europe and the US.
For further information please email:
It is based and located in Warsaw, Poland. Biotechnology World was
Logadassen Curoopen founded in 2007 to provide the world’s biotech and pharma information and market to
Conference Producer make it universally accessible and useful for scientifi c and business processes. Its fi rst step
to fulfi lling that mission was building the BIOTECHNOLOGY EUROPE platform that will
allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers
companies completed internet public relations, publication and marketing solutions. One of
the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector
in Europe to global biotechnology, pharmaceutical and life science activities.
For further information please visit
Future Pharmaceuticals has forged powerful relationships
Driving the Industry Forward |

Who should attend? with key industry leaders to provide a platform for successful
brand recognition, and for senior decision-makers to have the means to procure and
plan implementation strategies based on the topics covered. Positioned to be an
Vice/Presidents, Directors, Heads of:- authoritative resource within top pharma companies as well as small, specialty, and
biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into
• Lifecycle Management a highly targeted and responsive audience, bridging the gap between the industries’
top issues and the solutions top-tier vendors can provide.
• Portfolio Management Research & Development For further information please visit:
InPharm is the online platform for exclusive pharmaceutical news,
comment, contracts, services, jobs and events and is home to
• Strategic Planning Partnering, Pharmafi le and Pharmafocus.
For further information please visit:
• Licensing & Alliance Pharma Connections Worldwide® is the leading professional
business networking website focused in the Pharmaceutical,
• Process Chemists, Pre-Formulation Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for
delivery of premiere content coupled with the right clientele in order to facilitate business
• Formulation Clinical Scientists development opportunities among industry professionals responsible for making key
decisions in a global marketplace.
For further information please visit:
• Clinical Investigators

• Brand Management
Sponsorship and exhibition opportunities:
• Patent This event offers a unique opportunity to meet and do business with some of the key players in
the pharmaceutical and biotech industries. If you have a service or product to promote, you can
• Regulatory Affairs do so at this event by:
• Hosting a networking drinks reception
Target audience - industry • Taking an exhibition space at the conference
• Advertising in the delegate documentation pack
Pharmaceutical companies, biopharmaceutical • Providing branded bags, pens, gifts, etc.
If you would like more information on the range of sponsorship or exhibition possibilities for
companies, software vendors, PLM vendors, Analysts, 4th Annual Pharmaceutical PLM Conference 2010, Please contact us:

Consultants S. Raju,

Day 1
4th Annual Pharmaceutical PLM
Tuesday 14th September 2010

09:00 Registration and refreshments 12:40 Lunch

09:30 Chair’s opening remarks 13:40 Enhancing life cycle management through effective
enior Representative
pharmaceutical licensing strategies
Infosys • Examining the licensing process in pharmaceutical industry

• Developing effective strategies while managing costs effectively

09:40 Towards an integrated PLM solution for
pharmaceutical industry – A perspective J onathan Deutsch
Director Pharma Development Safety, Licensing
• PLM maturity model and pharma challenges and Early Development
• Solution ideation, As Is landscape and business goals Hoffmann-La Roche

• Case study and Infosys credentials 14:20 Effective brand optimisation

mit Sharma • Development of intangible value
Head, PLM Europe, Infosys Product Lifecycle Engineering Services
Infosys • Planning for PLM - when is early? And when is too late?

• Best practice methodologies

10:20 Lifecycle management begins at phase II
• Yo-yo marketing – the customer IS king
• Evaluating commercial probability of success in early-stage portfolios
• Putting the ‘life’ in lifecycle
• Evaluating strategic options in phase II
aul FitzGerald
• Roadmapping product launch options Owner
Syntropy Medica
• What ‘great’ looks like: case studies of brands that managed early

ike Rea 15:00 Afternoon refreshments & networking session
Chief Executive Officer
15:20 Taking the pain out of the launch process
11:00 Morning refreshment & networking session • Ensuring consistency of label/graphics design

• Examining best of breed approaches to product launches

11:20 Developing differentiation, innovation, and long-
• Removing complexity of PLM
term growth strategies with lifecycle technologies
artin Hawkins
• Brief introduction on fundamentals of oral controlled release
Executive Director
• Product innovation through mechanistic changes in product design Sun Brand Technologies

• Examining drug delivery technologies as growth driver

16:00 Reformulation using new technologies as a strategy
• Big pharma and generic company perspective to lifecycle management
• Looming patent losses for big pharma • Examples on how new technology and patent protection can maximise
• Examining how emerging markets drive growth the value of a product.

ishal K. Gupta • How the clinical benefit needs to be balanced to the clinical and
Director, Pharmaceutical R&D regulatory requirements.
Covidien • The importance of a timely lifecycle management strategy

eter G Nielsen
12:00 Maximising ROI through patent protection strategies
Executive Vice President of Pharmaceutical Development and
• Understanding how to effectively reassess, develop and exploit patent Chemistry Manufacturing & Control
protection strategies Lifecycle Pharma
• Enhancing market exclusivity and revenue returns over the lifecycles
of new drugs 16:40 Chair’s closing remarks

• Successful case scenarios on strategy application

igel Stoate
Partner 16:50 Networking drinks
Taylor Wessing Take your discussions further and build new
relationships in a relaxed and informal setting
Day 2
4th Annual Pharmaceutical PLM
Wednesday 15th September 2010

09:00 Registration and refreshments 12:40 Lunch

09:30 Chair’s opening remarks 13:40 Evaluating technical and integration issues in PLM

arc Sluijs • Understanding the implementation process of PLM solutions
EMEA Business Development Director Life Sciences • Customisation and configuration issues within the pharmaceutical environment
• Configurable packages versus customised PLM projects

• Discuss successful PLM strategies

09:40 Mergers and acquisitions: The need for PLM tools
• How does it affect the longer term delivery by the vendors to
14:20 Presentation to be announced
the customers?
Lorna Brazell
• Harmonising the product portfolio and enhancing visibility across
the value chain
Bird & Bird
• Managing portfolio of drug candidates – from research to
development and beyond
15:00 Afternoon refreshments & networking session
lok Aggarwal
Co-Founder and Chairman
15:20 Strategic product portfolio life cycle management
• Complexity and performance of the Product life cycle process
10:20 Optimising life cycle management through • Key objectives of Product portfolio Life Cycle Management PLCM
efficiency measurements
• Model based PLCM
• Explaining why is there a need to measure
- Conceptual design and structure
• Identifying appropriate efficiency measurement tools
- Operational concept, Managers user interface und demonstration of
• Defining the challenges case studies
• Exploring some best practice examples • Benefits
lexandra C. Gruber M
atej Janovjak
Director Business Development & Marketing CEO
BIOCRATES Life Sciences InSysteA

11:00 Morning refreshment & networking session 16:00 Managing drug safety throughout product
lifecycle management
• Understanding the benefit-risk decision making by prescribers and patients

• Adaptative design for RMP/REMS based on their outcome

11:20 Panel Discussion: - The role of partnership in
• Best practices for developing transparency with safety governance committees
implementing PLM software
alph C. Schimmer
P anelists will identify and understand how partnerships with technology
Global Head Drug Safety Sciences - Metabolism and Cardiovascular
vendors can maximise value through an efficient PLM implementation.
F.Hoffmann-La Roche
If you want to submit a question, please email it to
arc Sluijs 16:40 Chair’s closing remarks
EMEA Business Development Director Life Sciences
16:50 End of conference

12:00 Managing brands across the four phases of

product lifecycle